De Toni Luca, Šabovic Iva, Cosci Ilaria, Ghezzi Marco, Foresta Carlo, Garolla Andrea
Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.
Department of Clinical and Experimental Oncology, IOV-IRCCS, Padova, Italy.
Front Endocrinol (Lausanne). 2019 Jul 2;10:408. doi: 10.3389/fendo.2019.00408. eCollection 2019.
Testicular cancer (TC) represents one of the most peculiar clinical challenges at present. In fact, currently treatments are so effective ensuring a 5 years disease-free survival rate in nearly 95% of patients. On the other hand however, TC represents the most frequent newly diagnosed form of cancer in men between the ages of 14 and 44 years, with an incidence ranging from <1 to 9.9 affected individuals per 100,000 males across countries, while the overall incidence is also increasing worldwide. Furthermore, cancer survivors show a 2% risk of developing cancer in the contralateral testis within 15 years of initial diagnosis. This complex and multifaceted scenario requires a great deal of effort to understand the clinical base of available evidence. It is now clear that genetic, environmental and hormonal risk factors concur and mutually influence both the development of the disease and its prognosis, in terms of response to treatment and the risk of recurrence. In this paper, the most recent issues describing the relative contribution of the aforementioned risk factors in TC development are discussed. In addition, particular attention is paid to the exposure to environmental chemical substances and thermal stress, whose role in cancer development and progression has recently been investigated at the molecular level.
睾丸癌(TC)是目前最特殊的临床挑战之一。事实上,目前的治疗非常有效,能确保近95%的患者实现5年无病生存率。然而,另一方面,睾丸癌是14至44岁男性中最常见的新诊断癌症形式,各国每10万名男性中受影响个体的发病率在<1至9.9之间,而且全球总体发病率也在上升。此外,癌症幸存者在初次诊断后的15年内,对侧睾丸发生癌症的风险为2%。这种复杂多面的情况需要付出巨大努力来了解现有证据的临床基础。现在很清楚,遗传、环境和激素风险因素共同作用并相互影响疾病的发生发展及其预后,包括对治疗的反应和复发风险。本文讨论了描述上述风险因素在睾丸癌发生中相对作用的最新问题。此外,特别关注了环境化学物质暴露和热应激,最近已在分子水平上研究了它们在癌症发生和进展中的作用。